Lyra Therapeutics, Inc.LYRANASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank8
Year-over-Year Change
Year-over-year gross profit growth rate
Percentile
P8
Near historical low
vs 3Y Ago
-3.3x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -341.18% |
| Q2 2025 | -109.29% |
| Q1 2025 | -12.44% |
| Q4 2024 | 7.18% |
| Q3 2024 | -67.39% |
| Q2 2024 | 51.01% |
| Q1 2024 | 549.18% |
| Q4 2023 | 100.52% |
| Q3 2023 | -14.34% |
| Q2 2023 | -2622.20% |
| Q1 2023 | 103.24% |
| Q4 2022 | -3620.89% |
| Q3 2022 | 104.24% |
| Q2 2022 | -15.42% |
| Q1 2022 | 37.67% |
| Q4 2021 | -84.99% |
| Q3 2021 | 0.66% |
| Q2 2021 | -34.28% |
| Q1 2021 | -27.44% |
| Q4 2020 | -0.84% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |